In light of the promising evidence regarding the beneficial effects of GLP-1 RAs in glycemic control and weight reduction, their use in diabetic and obese patients, respectively, has increased substantially
Health technology assessment (Winchester, England) , 13 (27), iii163
It should be refrigerated at all times to maintain its stability and potency
In one clinical trial, 1,961 participants experienced an average weight loss of 14.9% after taking 2.4mg of semaglutide for 68 weeks: Other studies demonstrate varying amounts lost, usually over six months to 68 weeks
At this time, its unclear about the long-term ramifications of this decision